Decision Intelligence Platform for MSL Teams

Cover 5-10x More HCPs
With the Same MSL Team

MSL teams are not hired to manage spreadsheets. Automate KOL discovery, insights, and outreach — and get back to real field impact.

Built for real-world MSL workflowsSame-day insightsNo proprietary data lock-in

The Problem

Medical Affairs is still running on spreadsheets and outdated technology

Stale Data

Static KOL lists outdated the moment they're delivered

Blind Spots

No visibility into community-level providers who drive real-world prescribing

Manual Work

MSLs wasting hours on manual research across disconnected tools and spreadsheets

No Prioritization

No systematic way to prioritize outreach or measure engagement impact

Siloed Teams

No coordination across territories, therapeutic areas, or team members

“Medical Affairs is still operating on spreadsheets in a world that demands real-time intelligence.”

Early Access Partner

The Platform

From Fragmented Workflows to Unified Intelligence

Four pillars that transform how MSL teams discover, decide, execute, and measure.

01

Intelligent Discovery

Find who actually matters

  • Go beyond top-tier academic KOLs
  • Find real-world treaters & influencers
  • Disease-specific intelligence
Multiple Myeloma — Northeast US
All ResultsAcademicCommunity
SK

Dr. Sarah Kim

Hematology / Oncology

87
MR

Dr. Michael Rivera

Rheumatology

72
JT

Dr. Jennifer Torres

Immunology

65
247 KOLs found
1
2
3
02

Custom Identifier Builder

Stack filters, surface exactly who you need

  • Combine unlimited filter dimensions
  • Disease, claims, trials, region & more
  • Results update in real time
Build your search...

Active Filters

Specialty:RheumatologyDisease:Rheumatoid ArthritisDrug Signal:JAK InhibitorsClaims:>200/yearRegion:Northeast USTrial Status:Active Phase III

Add Filter

Publication CountH-IndexGrant FundingCongress SpeakerAdvisory BoardEngagement HistoryInstitution TypeNPI Taxonomy
89 KOLs matched
0.4s
32 Tier 1Scored by relevance6 filters active
03

AI-Enabled Outreach

Personalized at scale

Generate context-aware outreach drafts grounded in each KOL's publication history, trial activity, and past interactions.

AI Outreach DraftAI Generated
SK

Dr. Sarah Kim

Hematology / Oncology — Boston, MA

Subject: Your recent PFS data in r/r DLBCL

Dr. Kim — Your ASH poster on bispecific combinations showed promising 18-month PFS. We'd love to discuss how this aligns with our Phase III...

Personalized from 12 publications
Send EmailEdit DraftRegenerate
04

Field Execution

Walk in prepared

Equip MSLs with AI-generated pre-call briefs, real-time insights, and smart territory prioritization before every meeting.

Pre-Call BriefReady
MR

Dr. Michael Rivera

Northwestern — March 22, 2:30 PM

Key Topics

Recent Phase III data in RA

Upcoming ACR presentation

Advisory board follow-up

Last: Jan 14 — Discussed biosimilar positioning

Product Suite

One platform, every capability

Purpose-built modules that work together to power your entire medical affairs operation.

KOL Intelligence

Advanced multi-criteria search with scored, tiered results. Build queries as specific as your strategy demands.

Search KOLs by name, specialty, or institution...
Breast CancerNortheast USScore > 80Phase III
SC
Dr. Sarah Chen
Oncology · Boston, MA
94
JW
Dr. James Whitfield
Hematology · Houston, TX
87
PP
Dr. Priya Patel
Immunology · San Francisco, CA
82

Community Mapping

Surface real-world treatment centers and community specialists beyond academic KOLs.

Territory Overview
Tier 1
Tier 2
Tier 3
147
Active HCPs
23
Territories
89%
Coverage

Pre-Call Intelligence

Auto-generated KOL briefs with publications, trials, and affiliations.

Dr. Sarah Chen
Oncology · Dana-Farber Cancer Institute
Key Publications
Trial Involvement
Active
Completed
Talking Points

MSL Workflow Layer

Territory planning, call planning, and lightweight interaction logging.

Planned2
Dr. Chen — Follow-up
High
Congress prep
Med
In Progress1
Regional mapping
High
Complete1
Q4 territory review

Insights Capture

Capture field insights, structure them automatically, feed back into strategy.

New Insight
Draft
HCP
Dr. Sarah Chen
Category
Clinical
Research
Market
Notes

Competitive Intelligence

Monitor competitor engagement, track trial activity shifts, spot emerging KOLs.

Metric
You
Comp A
Trend
KOL Engagements
142
98
Trial Starts
12
15
Publications
47
31
Congress Presence
8
11

Analytics & Impact

Engagement heatmaps, influence changes over time, coverage gap identification.

Engagement Impact
12 mo
Influence Score Trend
+18.4%

Why Now

The old model doesn't scale

01

Explosion of Data

Publications, trials, and real-world evidence growing exponentially. No team can keep up manually.

02

Shift to Community Care

Treatment moving beyond academic centers to community providers. Your data needs to follow.

03

Leaner MSL Teams

Teams asked to do more with fewer resources. Every interaction needs to count.

04

Pressure to Show ROI

Leadership demanding measurable impact from Medical Affairs. Gut-feel strategy is no longer enough.

Why Bionara

Built different from legacy platforms

Feature
Traditional Platforms
Bionara
Data Delivery
Static lists
Real-time dashboards
KOL Coverage
Academic KOLs only
All KOL types incl. community
Purpose
Data delivery
MSL execution & workflows
Customization
One-size-fits-all lists
Hyper-specific query parameters
Speed to Insight
Weeks of manual research
Same-day answers

Use Cases

Built for the moments that matter

01

Launch Planning

Don't just find the top experts — surface every type of HCP profile you need for your niche. Bionara maps the full landscape pre-launch so your team walks in with complete coverage from day one.

Launch Timeline
Q1Q2Q3Q4
Identify Tier-1 KOLs
Advisory Board
Preceptorship
Congress Engagement
Launch Readiness
02

Territory Optimization

Know exactly where MSLs should spend their time for maximum impact. Our heatmap analysis reveals opportunity density across every territory in your footprint.

Territory Heatmap
KOLsCoverageActivityROI
Northeast
Southeast
Midwest
West
Southwest
03

Automated Outreach

Run custom, AI-driven outreach for every type of HCP — from Tier-1 KOLs to community treaters. MSLs only get looped in when an HCP is responsive, and your team can alter the outreach strategy at any time.

Outreach Pipeline
5 HCPs · 2 responsive
SK

Dr. Sarah Kim

Tier-1 KOL

EmailResponded
JP

Dr. James Park

Community Treater

EmailAI Outreach
LM

Dr. Lisa Martinez

Rising Investigator

LinkedInAI Outreach
RH

Dr. Robert Hall

Community Treater

In-PersonMSL Looped In
AT

Dr. Anna Torres

Digital Influencer

EmailResponded
MSLs only looped in on responsive HCPsEdit Strategy →
04

Community Expansion

Discover community-level treaters and non-obvious influencers. Map the networks that connect academic KOLs to the providers actually treating patients in your disease area — and keep it all persistent and visible to your entire company over time.

Network Graph
10 nodes · 14 connections
Hub KOL
Connected HCP

Early Results

Proven in the field

80%Reduction in research time
3xMore relevant HCPs identified
5-10xMSL output multiplier

“Bionara gave us visibility into community treaters we never knew existed. It changed how we plan our territory.”

— Early Access Partner

Free Your MSLs From Manual Work

See how Bionara can leverage your team with workflows they already know.